Summary
Silicon is known to ensure an essential role in the formation of cross-links between collagen and proteoglycans during bone growth. In this study, we have evaluated the short-term effects of a preventive treatment with silanol, a soluble organic silicon (Si), on trabecular bone in mature ovariectomized rats. Three-month-old rats were shamoperated (sham) or were ovariectomized (OVX) and treated with 10 μg/kg/day of 170 estradiol (E2), or with 0.1 mg Si/kg/day or 1.0 mg Si/kg/day of silanol for 1 month. Plasma alkaline phosphatase and osteocalcin levels were increased by 50% in OVX rats compared with sham rats and were corrected by E2 but not by silanol treatment. The trabecular bone volume measured at the tibial metaphysis was decreased by 48%, and histomorphometric indices of bone resorption and formation were increased in OVX rats compared with sham, and these parameters were corrected by E2 treatment. Treatment of OVX rats with silanol decreased the osteoclast surface by 31% and the number of osteoclasts by 20%. The mineral apposition rate, the bone formation rate, and the osteoblast surface at the tibia metaphyseal area were increased by 30% at the higher dose of silanol compared with OVX rats. In contrast, silanol treatment had no effect on the periosteal apposition rate. The reduction of the metaphyseal bone resorption and the increased bone formation induced by silanol resulted in a slight improvement of the trabecular bone volume (+ 14%) compared with controls. The results indicate that a short-term preventive treatment with the organic silicon silanol partially prevented the trabecular bone loss in mature OVX rats by reducing bone resorption and increasing bone formation, possibly through stimulatory effects on the formation and/or the stability of the organic bone matrix.
Similar content being viewed by others
References
Parfitt AM (1984) Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biochemical consequences. Calcif Tissue Int 36:S123-S128
Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681–686
Wronski TJ, Dan LM, Scott KS, Crooke LIZ (1989) Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 125:810–816
Hayashi T, Yamamuro T, Okumurah, Kasai R, Toda K (1989) Effect of eel calcitonin on the prevention of osteoporosis induced by combination of immobilization and ovariectomy in the rat. Bone 10:25–28
Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, DeLuca PP (1991) Skeletal effects of calcitonin in ovariectomized rats. Endocrinology 129:2246–2250
Hock JM, Gera I, Fonseca J, Raisz LG (1988) Human PTH (1–34) increases bone in ovariectomized and orchidectomized rats. Endocrinology 122:2899–2903
Hori M, Usawa T, Morita K, Noda T, Takahashi H, Inoue J (1988) Effect of human parathyroid hormone (PTH 1–34) on experimental osteopenia of rats induced by ovariectomy. J Bone Miner Res 3:193–199
Modrowski D, Miravet L, Feuga M, Bannié F, Marie PJ (1992) Effect of fluoride on bone and bone cells in ovariectomized rats. J Bone Miner Res 7:961–969
Ke HZ, Li M, Jee WSS (1992) Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats. Bone Miner 19:45–62
Mori S, Jee WSS, Li XJ (1992) Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2. Calcif Tissue Int 50:80–87
Marie PJ, Hott M, Modrowski D, De Pollack C, Guillemain J, Deloffre P, Tsouderos Y (1993) An uncoupling agent containing strontium (S 12911) prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–615
Laponche AM, Corriol S, Chauvin M, Eisinger J (1977) Osteoporoses: technique d'exploration et therapeutique nouvelle. Lyon Mediter Med 13:1349–1351
Schiano A, Eisinger F, Detolle P, Laponche AM, Brisou B, Eisinger J (1979) Silicium, tissu osseux et immunité. Rev Rhumat 46:483–486
Schwarz K (1973) A bound form of silicon in glycosaminoglycans and polyuronides. Proc Natl Acad Sci 70:1608–1612
Carlisle EM (1976) In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. J Nutr 106:478–484
Carlisle EM (1981) Silicon in bone formation, vol 4. In: Simpson TL, Volcani BE (eds) Springer Verlag, New York pp 69–94
Allain P, Cailleux A, Mauras Y, Renier JC (1983) Etude de l'absorption digestive du silicium après administration unique chez l'homme sous forme de salicylate de methylsilanetriol. Therapie 38:171–174
Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175–192
Wronski TJ, Yen C-F (1991) The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Mater S1:69–74
Wronski TJ, Schenck PA, Cintron M, Walsh CC (1987) Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 40:155–159
Modrowski D, Del Pozo E, Miravet L (1992) Dynamics of circulating osteocalcin in rats during growth and under experimental conditions. Horm Met Res 24:474–477
Baron R, Vignery A, Neff L, Silverglate A, Maria AS (1983) Processing of undecalcified bone specimens for bone histomorphometry. In: Recker RR (ed) Bone histomorphometry. CRC Press Inc, Boca Raton, FL, pp 13–36
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 6:595–610
Turner TT, Vandersteenhoven JJ, Bell NH (1984) The effect of ovariectomy and l7β estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115–122
Wronski TJ, Cintron M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179–183
Chow JWM, Lean JM, Chambers TJ (1992) 17β-estradiol stimulates cancellous bone formation in female rats. Endocrinology 130:3025–3082
Turner RT, Colvard DS, Spelsberg TC (1990) Estrogen inhibition of periosteal bone formation in rat long bones: downregulation of gene expression for bone matrix proteins. Endocrinology 127:1346–1351
Eisinger J, Clairet D, Zakarian H, Ouaniche J, Beyssac M, Arroyo P, Arroyo H (1990) Evolution a court terme des osteoporoses traitées: étude absorptiométrique. Médecine du Sud Ouest 26:323–325
Keeting PE, Oursler MJ, Wiegand KE, Bonde SK, Spelsberg TC, Riggs BL (1992) Zeolite A increases proliferation, differentiation and transforming growth factor β production in normal human adult osteoblast-like cells in vitro. J Bone Miner Res 7:1281–1289
Brady MC, Dobson PRM (1991) Zeolite A stimulates proliferation and protein synthesis in human osteoblast-like cells and the osteosarcoma cell line MG 63. J Bone Miner Res 6:S139
Modrowski D, Miravet L, Feuga M, Marie PJ (1993) Increased proliferation of osteoblast precursor cells in estrogen-deficient rats. Am J Physiol 264 (Endocrinol Metab 27):E190-E196
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hott, M., de Pollak, C., Modrowski, D. et al. Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int 53, 174–179 (1993). https://doi.org/10.1007/BF01321834
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01321834